Free Trial

MarketBeat Instant News Alerts

Iovance Biotherapeutics logo with Medical background

Iovance Biotherapeutics (NASDAQ:IOVA) Price Target Lowered to $20.00 at HC Wainwright

MarketBeat

HC Wainwright decreased their price target on Iovance Biotherapeutics from $32.00 to $20.00 and set a "buy" rating on the stock in a research note on Friday.

NASDAQ:IOVA
Read Iovance Biotherapeutics (NASDAQ:IOVA) Price Target Lowered to $20.00 at HC Wainwright
Hut 8 logo with Finance background

Hut 8 (NASDAQ:HUT) Earns "Buy" Rating from HC Wainwright

MarketBeat

HC Wainwright reiterated a "buy" rating and issued a $25.00 price objective on shares of Hut 8 in a report on Friday.

NASDAQ:HUT
Read Hut 8 (NASDAQ:HUT) Earns "Buy" Rating from HC Wainwright
Hut 8 logo with Finance background

Needham & Company LLC Reiterates Buy Rating for Hut 8 (NASDAQ:HUT)

MarketBeat

Needham & Company LLC restated a "buy" rating and issued a $21.00 target price on shares of Hut 8 in a report on Friday.

NASDAQ:HUT
Read Needham & Company LLC Reiterates Buy Rating for Hut 8 (NASDAQ:HUT)
4D Molecular Therapeutics logo with Medical background

4D Molecular Therapeutics (NASDAQ:FDMT) Given New $38.00 Price Target at Barclays

MarketBeat

Barclays reduced their price objective on shares of 4D Molecular Therapeutics from $45.00 to $38.00 and set an "overweight" rating for the company in a research note on Friday.

NASDAQ:FDMT
Read 4D Molecular Therapeutics (NASDAQ:FDMT) Given New $38.00 Price Target at Barclays
National Vision logo with Consumer Staples background

National Vision (NASDAQ:EYE) Upgraded at Citigroup

MarketBeat

Citigroup raised shares of National Vision from a "neutral" rating to a "buy" rating and raised their price target for the company from $13.00 to $21.00 in a research report on Friday.

NASDAQ:EYE
Read National Vision (NASDAQ:EYE) Upgraded at Citigroup
Dyne Therapeutics logo with Medical background

Chardan Capital Reaffirms Buy Rating for Dyne Therapeutics (NASDAQ:DYN)

MarketBeat

Chardan Capital reiterated a "buy" rating and set a $50.00 price target on shares of Dyne Therapeutics in a report on Friday.

NASDAQ:DYN
Read Chardan Capital Reaffirms Buy Rating for Dyne Therapeutics (NASDAQ:DYN)

Trending News

All MarketBeat Instant News Alerts

DraftKings logo with Consumer Discretionary background

DraftKings (NASDAQ:DKNG) Given Buy Rating at Needham & Company LLC

MarketBeat
NASDAQ:DKNG
Read DraftKings (NASDAQ:DKNG) Given Buy Rating at Needham & Company LLC
CVRx logo with Medical background

CVRx (NASDAQ:CVRX) Receives "Underweight" Rating from JPMorgan Chase & Co.

MarketBeat
NASDAQ:CVRX
Read CVRx (NASDAQ:CVRX) Receives "Underweight" Rating from JPMorgan Chase & Co.
Core Scientific logo with Finance background

Core Scientific (NASDAQ:CORZ) Given "Buy" Rating at Canaccord Genuity Group

MarketBeat
NASDAQ:CORZ
Read Core Scientific (NASDAQ:CORZ) Given "Buy" Rating at Canaccord Genuity Group
Coinbase Global logo with Finance background

Coinbase Global (NASDAQ:COIN) Given Buy Rating at Canaccord Genuity Group

MarketBeat
NASDAQ:COIN
Read Coinbase Global (NASDAQ:COIN) Given Buy Rating at Canaccord Genuity Group
CarGurus logo with Auto/Tires/Trucks background

Needham & Company LLC Has Lowered Expectations for CarGurus (NASDAQ:CARG) Stock Price

MarketBeat
NASDAQ:CARG
Read Needham & Company LLC Has Lowered Expectations for CarGurus (NASDAQ:CARG) Stock Price
Aurora Innovation logo with Business Services background

Aurora Innovation (NASDAQ:AUR) Price Target Raised to $13.00 at Needham & Company LLC

MarketBeat
NASDAQ:AUR
Read Aurora Innovation (NASDAQ:AUR) Price Target Raised to $13.00 at Needham & Company LLC
Arhaus logo with Retail/Wholesale background

Arhaus' (ARHS) Market Perform Rating Reaffirmed at Telsey Advisory Group

MarketBeat
NASDAQ:ARHS
Read Arhaus' (ARHS) Market Perform Rating Reaffirmed at Telsey Advisory Group
Appian logo with Computer and Technology background

Appian (NASDAQ:APPN) Given New $33.00 Price Target at Barclays

MarketBeat
NASDAQ:APPN
Read Appian (NASDAQ:APPN) Given New $33.00 Price Target at Barclays
Allegro MicroSystems logo with Computer and Technology background

Needham & Company LLC Cuts Allegro MicroSystems (NASDAQ:ALGM) Price Target to $25.00

MarketBeat
NASDAQ:ALGM
Read Needham & Company LLC Cuts Allegro MicroSystems (NASDAQ:ALGM) Price Target to $25.00
Knight-Swift Transportation logo with Transportation background

What is Zacks Research's Estimate for KNX Q2 Earnings?

MarketBeat
NYSE:KNX
Read What is Zacks Research's Estimate for KNX Q2 Earnings?
Keros Therapeutics logo with Medical background

Leerink Partnrs Has Negative Estimate for KROS Q2 Earnings

MarketBeat
NASDAQ:KROS
Read Leerink Partnrs Has Negative Estimate for KROS Q2 Earnings
Keros Therapeutics logo with Medical background

Q2 EPS Forecast for Keros Therapeutics Lowered by Analyst

MarketBeat
NASDAQ:KROS
Read Q2 EPS Forecast for Keros Therapeutics Lowered by Analyst
Keros Therapeutics logo with Medical background

Q2 EPS Forecast for Keros Therapeutics Decreased by Analyst

MarketBeat
NASDAQ:KROS
Read Q2 EPS Forecast for Keros Therapeutics Decreased by Analyst
Limbach logo with Construction background

Roth Capital Issues Negative Outlook for Limbach Earnings

MarketBeat
NASDAQ:LMB
Read Roth Capital Issues Negative Outlook for Limbach Earnings
Lemonade logo with Finance background

What is William Blair's Forecast for Lemonade Q2 Earnings?

MarketBeat
NYSE:LMND
Read What is William Blair's Forecast for Lemonade Q2 Earnings?
Louisiana-Pacific logo with Construction background

Seaport Res Ptn Issues Negative Estimate for LPX Earnings

MarketBeat
NYSE:LPX
Read Seaport Res Ptn Issues Negative Estimate for LPX Earnings
LTC Properties logo with Finance background

What is Wedbush's Estimate for LTC Properties Q2 Earnings?

MarketBeat
NYSE:LTC
Read What is Wedbush's Estimate for LTC Properties Q2 Earnings?
Southwest Airlines logo with Transportation background

Zacks Research Issues Pessimistic Estimate for LUV Earnings

MarketBeat
NYSE:LUV
Read Zacks Research Issues Pessimistic Estimate for LUV Earnings
Las Vegas Sands logo with Consumer Discretionary background

Brokers Offer Predictions for Las Vegas Sands Q2 Earnings

MarketBeat
NYSE:LVS
Read Brokers Offer Predictions for Las Vegas Sands Q2 Earnings
Marcus logo with Consumer Discretionary background

Q2 EPS Estimates for Marcus Boosted by Barrington Research

MarketBeat
NYSE:MCS
Read Q2 EPS Estimates for Marcus Boosted by Barrington Research
Neurocrine Biosciences logo with Medical background

Research Analysts Issue Forecasts for NBIX Q2 Earnings

MarketBeat
NASDAQ:NBIX
Read Research Analysts Issue Forecasts for NBIX Q2 Earnings
Neurocrine Biosciences logo with Medical background

Research Analysts Offer Predictions for NBIX Q2 Earnings

MarketBeat
NASDAQ:NBIX
Read Research Analysts Offer Predictions for NBIX Q2 Earnings
National CineMedia logo with Business Services background

Q2 Earnings Forecast for NCMI Issued By Barrington Research

MarketBeat
NASDAQ:NCMI
Read Q2 Earnings Forecast for NCMI Issued By Barrington Research
National CineMedia logo with Business Services background

Q2 EPS Estimates for National CineMedia Reduced by Wedbush

MarketBeat
NASDAQ:NCMI
Read Q2 EPS Estimates for National CineMedia Reduced by Wedbush

Featured Articles and Offers

Sector News